Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05674136
Other study ID # CIP-1056
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 18, 2022
Est. completion date December 7, 2022

Study information

Verified date June 2024
Source Masimo Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to compare the equivalence of the Masimo INVSENSOR00061 to RD SET Neo for SpO2 and performance of PR and RRp as the subjects undergo a controlled desaturation protocol. This type of study design is required to evaluate the performance of pulse oximeters based upon the ISO 80601-2-61 standard which is also adopted and referenced by the FDA.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date December 7, 2022
Est. primary completion date December 7, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Subject is 18 to 50 years of age. - Subject weighs a minimum of 110 lbs. - Hemoglobin value = 11 g/dL. - Baseline heart rate = 45 bpm and = 85 bpm. - Blood Pressure: Systolic BP = 140 mmHg and = 90 mmHg, Diastolic BP = 90 mmHg and = 50 mmHg, and if systolic BP is lower than 100 mmHg and/or diastolic BP is lower than 60 mmHg, subject passes an orthostatic blood pressure test. - CO value = 3.0% FCOHb. - Subject is able to read and communicate in English and understands the study and the risks involved Exclusion Criteria: - Subject is pregnant. - Subject has a BMI > 35. - Subject is wearing nail polish that cannot be removed, gel nails, and/or acrylic nails that can interfere with study device's placement is deemed ineligible at the discretion of investigator/study staff. * - Subject has a history of fainting (vasovagal syncope), blacking out or losing consciousness during or after a blood draw, or has a fear of blood draws. - Subject has open wounds, inflamed tattoos or piercings, and/or has any visible healing wounds that a medical professional determines may place them at an increased risk for participation. * - Subject has known drug or alcohol abuse. - Subject uses recreational drugs. * - Subject experiences frequent or severe headaches and/or migraine headaches, migraine auras, altitude sickness, and/or headaches accompanied by visual changes or sensitivity to light or sound. - Subject has experienced a concussion or head injury with loss of consciousness within the past 12 months. - Subject has any history of a stroke, myocardial infarction (heart attack), and/or seizures. - Subject has any chronic bleeding disorder (e.g., hemophilia). - Subject has taken anticoagulant medication within the past 30 days (excluding nonsteroidal anti-inflammatory drugs (NSAIDS)). - Subject has donated blood within the past 4 weeks. - Subject has Wolff-Parkinson-White Syndrome or Stokes-Adams Syndrome. - Subject has any cardiac dysrhythmia (e.g., atrial fibrillation) and has not received clearance from their physician to participate. - Subject has a known neurological and/or psychiatric disorder (e.g., schizophrenia, bipolar disorder, Multiple Sclerosis, Huntington's disease) that interferes with the subject's level of consciousness. * - Subject has taken opioid pain medication 24 hours before the study. - Subject has any active signs and/or symptoms of infectious disease (e.g., Hepatitis, HIV, Tuberculosis, Flu, Malaria, Measles, etc.). * - Subject is taking medications known to treat any type of infectious disease. - Subject has either signs or history of peripheral ischemia or carpal tunnel syndrome. - Subject has had invasive surgery within the past year, including but not limited to major dental surgery, appendectomy, plastic surgery, jaw surgery, major ENT surgery, major abdominal and/or pelvic surgery, heart surgery, or thoracic surgery. * - Subject has symptoms of congestion, head cold, or other illnesses. - Subject has been in a severe car accident(s) or a similar type of accident(s) requiring hospitalization within the past 12 months. - Subject has any cancer or history of cancer (not including skin cancer). * - Subject has chronic unresolved asthma, lung disease (including COPD) and/or respiratory disease. - Subject is allergic to lidocaine, chlorhexidine, latex, adhesives, or plastic. - Subject has a heart condition, insulin-dependent diabetes, or uncontrolled hypertension. - Subject has delivered vaginally, has had a pregnancy terminated, a miscarriage with hospitalization or had a C-section within the past 6 months. - Subject intends on participating in any heavy lifting, repetitive movement of their wrist (including riding a motorcycle, tennis), exercise (working out, riding a bike, riding a skateboard, etc.), or any activity that will put additional stress on the wrist within 24 hours following a study that involves an arterial line. - Subject has any medical condition which in the judgment of the investigator and/or medical staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff. (*)Physician's discretion.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
INVSENSOR00061
Noninvasive pulse oximeter sensor

Locations

Country Name City State
United States Masimo Corporation Irvine California

Sponsors (1)

Lead Sponsor Collaborator
Masimo Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary SpO2 Accuracy SpO2 accuracy was determined by calculating the root mean-squared (rms) difference between the measured values (SpO2i) to the reference values (SpO2ref_i) in accordance with ISO-80601-2-61. Arms= v(?(i=1 to n) ((SpO2_i-SpO2ref_i )^2 ))/n 1-3 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1